Home › Lung Cancer › California › Santa Barbara
Lung Cancer clinical trials in Santa Barbara, CA
3 studies for Lung Cancer are looking for participants at sites in and around Santa Barbara (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecruitingPhase 3
- Sansum Clinic, Santa Barbara
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Ridley-Tree Cancer Center, Santa Barbara
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Sansum Clinic, Santa Barbara
- Sansum Clinic, Solvang · 28 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA63 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Chicago, IL43 studies
- Arlington, VA42 studies
- Washington, DC41 studies
- Baltimore, MD41 studies
- Nashville, TN39 studies
- St. Louis, MO37 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Santa Barbara
- Cancer (all types)7 studies
- Non-Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Ovarian Cancer4 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Prostate Cancer3 studies
- Metastatic Cancer3 studies
- Type 1 Diabetes3 studies
- Type 2 Diabetes3 studies
- Bladder Cancer3 studies
- Pulmonary Arterial Hypertension3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.